person

Maike C.

Country
Germany
Department
Abt. personalisierte Onkologie, Schwerpunkt Lungenkarzinom

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
38
Sites with multiple studies

Has run more than one trial at 38 of 189 partner sites.

Specializations

Lung Cancer Therapeutics

The investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular focus on patients with specific genetic mutations. Their research encompasses innovative targeted therapies for stage IV lung cancer patients.

  • EGFR Mutation Analysis
  • KRAS G12C-Positive NSCLC Treatment
  • Advanced Stage Cancer Management

Their therapeutic expertise extends to novel combinations of targeted therapy and chemotherapy for specific mutation profiles.

Precision Oncology

The investigator focuses on molecular-targeted therapeutic approaches, particularly in the treatment of specific genetic alterations in lung cancer. Their work involves evaluating novel targeted agents against specific mutations.

  • Targeted Therapy Development
  • Mutation-Specific Treatment Strategies
  • Comparative Treatment Analysis

Their research encompasses evaluation of various targeted therapies including osimertinib, divarasib, sotorasib, and adagrasib.

Treatment Innovation

The investigator examines combination therapy approaches in advanced lung cancer, evaluating the efficacy of novel treatment combinations and comparing different therapeutic strategies.

  • Combination Treatment Protocols
  • Advanced Disease Management
  • Treatment Efficacy Assessment

Their work involves developing treatment strategies for patients with atypical mutations and previously treated advanced lung cancer.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.